Company
EyeBiotech Ltd.
EyeBiotech Ltd. has 1 drug tracked on RxWires: 1 in Phase 2/3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Remigromig | Phase 2/3 | Diabetic Macular Edema (DME) |
Latest
No recent events.
Follow EyeBiotech Ltd. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.